CA3024873A1 - Modified antimicrobial peptide derived from an arginine-rich domain - Google Patents

Modified antimicrobial peptide derived from an arginine-rich domain Download PDF

Info

Publication number
CA3024873A1
CA3024873A1 CA3024873A CA3024873A CA3024873A1 CA 3024873 A1 CA3024873 A1 CA 3024873A1 CA 3024873 A CA3024873 A CA 3024873A CA 3024873 A CA3024873 A CA 3024873A CA 3024873 A1 CA3024873 A1 CA 3024873A1
Authority
CA
Canada
Prior art keywords
peptide
arginine
antimicrobial peptide
hbcard
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3024873A
Other languages
English (en)
French (fr)
Inventor
Chiaho Shih
Heng-Li CHEN
Pei-Yi Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academia Sinica
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Publication of CA3024873A1 publication Critical patent/CA3024873A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA3024873A 2016-05-27 2017-05-25 Modified antimicrobial peptide derived from an arginine-rich domain Abandoned CA3024873A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662342415P 2016-05-27 2016-05-27
US62/342,415 2016-05-27
PCT/US2017/034489 WO2017205631A1 (en) 2016-05-27 2017-05-25 Modified antimicrobial peptide derived from an arginine-rich domain

Publications (1)

Publication Number Publication Date
CA3024873A1 true CA3024873A1 (en) 2017-11-30

Family

ID=60411947

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3024873A Abandoned CA3024873A1 (en) 2016-05-27 2017-05-25 Modified antimicrobial peptide derived from an arginine-rich domain

Country Status (14)

Country Link
US (2) US20190144510A1 (https=)
EP (1) EP3464329A4 (https=)
JP (1) JP7161263B6 (https=)
KR (1) KR102530478B1 (https=)
CN (1) CN109641938A (https=)
AU (1) AU2017270201A1 (https=)
BR (1) BR112018074478A2 (https=)
CA (1) CA3024873A1 (https=)
IL (1) IL263086A (https=)
MX (1) MX2018014490A (https=)
SG (1) SG11201809928VA (https=)
TW (1) TWI635095B (https=)
WO (1) WO2017205631A1 (https=)
ZA (1) ZA201807763B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202317598A (zh) * 2021-09-01 2023-05-01 美商艾姆麥克斯治療股份有限公司 具有抗微生物活性的胜肽
KR102544102B1 (ko) * 2021-11-05 2023-06-19 주식회사 레메디 상처 치료 및 항염증 활성을 가지는 펩타이드 및 이의 용도
US11713341B1 (en) 2022-06-17 2023-08-01 Vestaron Corporation Antimicrobial NCR13 variant peptides
CN116947974B (zh) * 2023-07-25 2025-03-11 武汉大学人民医院（湖北省人民医院） 一种来源于中药美洲大蠊的多聚精氨酸修饰肽及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4248297A (en) * 1996-09-03 1998-03-26 General Hospital Corporation, The Inhibition of viral replication
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
PL201419B1 (pl) 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
WO2014124047A1 (en) * 2013-02-06 2014-08-14 Academia Sinica Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain

Also Published As

Publication number Publication date
EP3464329A4 (en) 2020-08-26
EP3464329A1 (en) 2019-04-10
WO2017205631A1 (en) 2017-11-30
US12084479B2 (en) 2024-09-10
SG11201809928VA (en) 2018-12-28
MX2018014490A (es) 2019-06-24
KR20190001954A (ko) 2019-01-07
IL263086A (en) 2018-12-31
CN109641938A (zh) 2019-04-16
TWI635095B (zh) 2018-09-11
AU2017270201A1 (en) 2018-11-29
KR102530478B1 (ko) 2023-05-10
JP2019523220A (ja) 2019-08-22
ZA201807763B (en) 2020-10-28
US20190144510A1 (en) 2019-05-16
JP7161263B2 (ja) 2022-10-26
TW201808985A (zh) 2018-03-16
JP7161263B6 (ja) 2023-03-20
BR112018074478A2 (pt) 2019-03-19
US20210101939A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
US12084479B2 (en) Modified antimicrobial peptide derived from an arginine-rich domain
Lu et al. D-and unnatural amino acid substituted antimicrobial peptides with improved proteolytic resistance and their proteolytic degradation characteristics
Kosikowska et al. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
US6890902B2 (en) Cytotoxic modified lactoferrin peptides
JP6683601B2 (ja) 抗菌性ペプチド
Sharma et al. Short antimicrobial peptides
JP2001520631A (ja) 抗真菌性ペプチド
Ouyang et al. Improving the antimicrobial performance of amphiphilic cationic antimicrobial peptides using glutamic acid full-scan and positive charge compensation strategies
JP2004514644A (ja) 抗菌化合物および処方物
EP2782589A2 (en) Anti-microbial peptides and methods of use thereof
US10752657B2 (en) Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain
KR101341210B1 (ko) 신규한 항균 펩타이드 및 이의 용도
TWI403330B (zh) 低血球溶解性之抗微生物胜肽、醫藥組成物及其用途
JPH10508576A (ja) 抗真菌性ペプチド
Son et al. Effects of C-terminal residues of 12-mer peptides on antibacterial efficacy and mechanism
CN112778424B (zh) 嵌合肽r7及其应用
HK40005579A (en) Modified antimicrobial peptide derived from an arginine-rich domain
KR101624688B1 (ko) 신규한 락토페리신 유사 항진균 펩타이드 및 그의 조성물
KR101257222B1 (ko) 미생물에 대한 항생활성을 갖는 펩타이드 및 이를 포함하는 항생 펩타이드 조성물
US20240010693A1 (en) Peptides from human b-casein that have anti-bacterial activity
Sharma et al. Synthesis Characterization and Antibacterial Evaluation of Peptides and their Poly-N-Substituted Glycine Congeners
EP3335720A1 (en) C-di-gmp binding peptides
WO2020065595A1 (es) Lipopeptidos cortos con actividad antimicrobiana contra bacterias gram negativas y gram positivas
Cardoso et al. General applications and special focus on antimicrobial peptides

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20221125